IAUYX
Price
$26.65
Change
-$0.03 (-0.11%)
Updated
Jun 5 closing price
Net Assets
3.55B
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.22B
Interact to see
Advertisement

IAUYX vs RMEBX

Header iconIAUYX vs RMEBX Comparison
Open Charts IAUYX vs RMEBXBanner chart's image
Invesco Dividend Income Y
Price$26.65
Change-$0.03 (-0.11%)
VolumeN/A
Net Assets3.55B
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.22B
IAUYX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IAUYX vs. RMEBX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IAUYX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. IAUYX (3.56B). IAUYX pays higher dividends than RMEBX: IAUYX (1.63) vs RMEBX (1.16). IAUYX was incepted earlier than RMEBX: IAUYX (17 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than IAUYX (0.69). IAUYX is a more actively managed with annual turnover of: 40.00 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than IAUYX: RMEBX (250) vs IAUYX (1000). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. IAUYX (4.09). RMEBX return over 5 years is better than : 49.85 vs. IAUYX (33.51).
IAUYXRMEBXIAUYX / RMEBX
Total Expense Ratio0.691.0764%
Annual Report Gross Expense Ratio0.691.0764%
Fund Existence17 years11 years-
Gain YTD3.7675.34970%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets3.56B105B3%
Annual Yield % from dividends1.631.16141%
Returns for 1 year4.098.3049%
Returns for 3 years9.0517.9650%
Returns for 5 years33.5149.8567%
Returns for 10 years50.3068.2174%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA